Literature DB >> 28604442

Awareness, Willingness, and Use of Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Washington, DC and Miami-Dade County, FL: National HIV Behavioral Surveillance, 2011 and 2014.

Rudy Patrick1, David Forrest, Gabriel Cardenas, Jenevieve Opoku, Manya Magnus, Gregory Phillips, Alan Greenberg, Lisa Metsch, Michael Kharfen, Marlene LaLota, Irene Kuo.   

Abstract

INTRODUCTION: Despite the effectiveness of oral pre-exposure prophylaxis (PrEP) for HIV prevention, knowledge, and uptake of this new prevention intervention over time has not been fully studied. Using NHBS data from 2 urban areas highly impacted by HIV, we examined awareness, use, and willingness to use daily oral PrEP and factors associated with willingness to take oral PrEP among men who have sex with men (MSM) over time.
METHODS: MSM from Washington, DC and Miami, FL were recruited in 2011 and 2014 using venue-based sampling. Participants completed behavioral surveys and HIV testing. Awareness, use, and willingness to use oral PrEP were examined. Demographic and behavioral correlates of being "very likely" to use PrEP in 2011 and 2014 were assessed.
RESULTS: PrEP awareness increased from 2011 to 2014 in both cities (DC: 39.1%-73.8% and Miami: 19.4%-41.2%), but use remained low in 2014 (DC: 7.7%; Miami: 1.4%). Being very likely to use PrEP decreased over time in DC (61%-48%), but increased in Miami (48%-60%). In DC, minority race was associated with increased odds of being very likely to use PrEP, whereas reduced odds of being very likely to use PrEP was observed for MSM with 1 or 2-5 partners versus having 6+ partners. In Miami, a higher proportion of white versus Hispanic MSM reported being very likely to use PrEP in 2011, but this observation was reversed in 2014.
CONCLUSION: Geographic differences in awareness, use, and willingness to use PrEP indicate that innovative strategies are needed to educate MSM about this effective prevention strategy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28604442      PMCID: PMC5510477          DOI: 10.1097/QAI.0000000000001414

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  19 in total

1.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

2.  HIV medical providers' perceptions of the use of antiretroviral therapy as nonoccupational postexposure prophylaxis in 2 major metropolitan areas.

Authors:  Allan E Rodríguez; Amanda D Castel; Carrigan L Parish; Sarah Willis; Daniel J Feaster; Michael Kharfen; Gabriel A Cardenas; Kira Villamizar; Michael Kolber; Liliana Vázquez-Rivera; Lisa R Metsch
Journal:  J Acquir Immune Defic Syndr       Date:  2013-11-01       Impact factor: 3.731

3.  Surveillance of HIV risk and prevention behaviors of men who have sex with men--a national application of venue-based, time-space sampling.

Authors:  Duncan A MacKellar; Kathleen M Gallagher; Teresa Finlayson; Travis Sanchez; Amy Lansky; Patrick S Sullivan
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

4.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

5.  Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.

Authors:  Matthew J Mimiaga; Patricia Case; Carey V Johnson; Steven A Safren; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

6.  Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services.

Authors:  Albert Y Liu; Stephanie E Cohen; Eric Vittinghoff; Peter L Anderson; Susanne Doblecki-Lewis; Oliver Bacon; Wairimu Chege; Brian S Postle; Tim Matheson; K Rivet Amico; Teri Liegler; M Keith Rawlings; Nikole Trainor; Robert Wilder Blue; Yannine Estrada; Megan E Coleman; Gabriel Cardenas; Daniel J Feaster; Robert Grant; Susan S Philip; Richard Elion; Susan Buchbinder; Michael A Kolber
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

7.  No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting.

Authors:  Jonathan E Volk; Julia L Marcus; Tony Phengrasamy; Derek Blechinger; Dong Phuong Nguyen; Stephen Follansbee; C Bradley Hare
Journal:  Clin Infect Dis       Date:  2015-09-01       Impact factor: 9.079

8.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Kachit Choopanya; Michael Martin; Pravan Suntharasamai; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Praphan Kitisin; Pitinan Natrujirote; Somyot Kittimunkong; Rutt Chuachoowong; Roman J Gvetadze; Janet M McNicholl; Lynn A Paxton; Marcel E Curlin; Craig W Hendrix; Suphak Vanichseni
Journal:  Lancet       Date:  2013-06-13       Impact factor: 79.321

9.  Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.

Authors:  Dawn K Smith; Michelle Van Handel; Richard J Wolitski; Jo Ellen Stryker; H Irene Hall; Joseph Prejean; Linda J Koenig; Linda A Valleroy
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-11-27       Impact factor: 17.586

10.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321

View more
  20 in total

1.  Barriers and Facilitators to Seeking HIV Services in Chicago Among Young Men Who Have Sex with Men: Perspectives of HIV Service Providers.

Authors:  Lauren B Beach; George J Greene; Peter Lindeman; Amy K Johnson; Christian N Adames; Matthew Thomann; Patrick C T Washington; Gregory Phillips
Journal:  AIDS Patient Care STDS       Date:  2018-11       Impact factor: 5.078

2.  Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP).

Authors:  B E Meyerson; P C Dinh; J D Agley; B J Hill; D N Motley; G A Carter; W Jayawardene; P T Ryder
Journal:  AIDS Behav       Date:  2019-07

3.  Awareness, Willingness, and Perceived Efficacy of Pre-exposure Prophylaxis among Adolescent Sexual Minority Males.

Authors:  Alvin Gordián-Arroyo; Robert Garofalo; Lisa M Kuhns; Cynthia Pearson; Josh Bruce; D Scott Batey; Asa Radix; Uri Belkind; Marco A Hidalgo; Sabina Hirshfield; Eric W Schrimshaw; Rebecca Schnall
Journal:  J Urban Health       Date:  2020-10       Impact factor: 3.671

4.  Awareness and Interest in HIV Pre-Exposure Prophylaxis Among Street-Based Female Sex Workers: Results from a US Context.

Authors:  Catherine Tomko; Ju Nyeong Park; Sean T Allen; Jennifer Glick; Noya Galai; Michele R Decker; Katherine H A Footer; Susan G Sherman
Journal:  AIDS Patient Care STDS       Date:  2019-01-11       Impact factor: 5.078

5.  Gay and Bisexual Men's Strategies to Maintain Daily Adherence to Their HIV Pre-exposure Prophylaxis (PrEP) Medication: Results from a Qualitative Study.

Authors:  Christian Grov; Anthony W P Flynn; Alexa B D'Angelo; Javier Lopez-Rios; David W Pantalone; Ian W Holloway; Jeffrey T Parsons
Journal:  Prev Sci       Date:  2019-01

6.  Reddit on PrEP: Posts About Pre-exposure Prophylaxis for HIV from Reddit Users, 2014-2019.

Authors:  Penny S Loosier; Kaytlin Renfro; Monique Carry; Samantha P Williams; Matthew Hogben; Sevgi Aral
Journal:  AIDS Behav       Date:  2021-09-18

7.  How Do Gay and Bisexual Men Make Up for Missed PrEP Doses, and What Impact Does Missing a Dose Have on Their Subsequent Sexual Behavior?

Authors:  Christian Grov; Alexa B D'Angelo; Anthony W P Flynn; Javier Lopez-Rios; David W Pantalone; Ian W Holloway; Thomas H F Whitfield; Jeffrey T Parsons
Journal:  AIDS Educ Prev       Date:  2018-08

8.  Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.

Authors:  Roman Shrestha; Elizabeth E DiDomizio; Rayne S Kim; Frederick L Altice; Jeffrey A Wickersham; Michael M Copenhaver
Journal:  J Subst Abuse Treat       Date:  2020-06-15

9.  Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California.

Authors:  Julia L Marcus; Leo B Hurley; Dennis Dentoni-Lasofsky; Courtney G Ellis; Michael J Silverberg; Sally Slome; Jonathan M Snowden; Jonathan E Volk
Journal:  AIDS Care       Date:  2018-10-10

10.  Oral Pre-Exposure Prophylaxis (PrEP) for HIV Prevention in Adolescents and Young Adults.

Authors:  Tanya L Kowalczyk Mullins; Corinne E Lehmann
Journal:  Curr Pediatr Rep       Date:  2018-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.